EPN 0.00% 2.4¢ epsilon healthcare limited

Ann: Clinic Rollout Update, page-17

  1. 1,248 Posts.
    lightbulb Created with Sketch. 185
    There are a myriad of non-regulatory barriers to market entry for Medicinal Cannabis.

    When you consider that this week the RACP produced a literature review that opened with 'The RACP emphasises the need for caution until there is sufficient quality evidence to support the use of medicinal cannabis', you realise the need for education-driven clinics such as THCs are increasingly non-negotiable.

    https://www.mja.com.au/journal/2018...g-cannabinoids-perspective-royal-australasian
 
watchlist Created with Sketch. Add EPN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.